Abstract: A continuous form microstructure array device is constructed as a flexible elongate film laminate containing a plurality of microstructures or arrays of microstructures arranged serially lengthwise along the laminate. The laminate can be continuously drawn from a supply roll or stack, advanced within an analytic device and, when analysis is complete, taken up in a storage roll or stack. The device provides for high throughput microfluidic processing.

Abstract: A compound handling system handles a multiplicity of chemical or biological compounds or samples, and is especially adapted for high throughput screening of compounds that are stored and handled in aliquotted form. Aliquots are contained in individual containers and the containers are arranged in racks having holding spaces open at opposite ends. Insertion and removal of the containers is effected in either direction of movement, and each container may be sealed with foil to protect its integrity.

Abstract: In a fluid catalytic cracking (FCC) unit, a regenerator, a stripper or a withdrawal well connecting to either of the vessels, includes a standpipe for circulating catalyst from one vessel to another, the standpipe having an inlet design which reduces gas entrainment during catalyst transport by partial de-fluidization in the standpipe inlet region. The standpipe inlet design could include multiple inlet openings through the top of the standpipe or from the side wall by slots, or both, and a horizontal disk surrounding the standpipe below the slots for blocking the upward flow of bubbles, the combination thereby forming a dense fluidization zone above the disk and surrounding the inlet, including the slots. Additionally, the disk may include a downwardly-projecting lip or edge forming an inverted void space around the standpipe and the downwardly-projecting edge may further include vent holes around its circumference which allow bubbles trapped under the disk to be vented outside the standpipe inlet region.

Abstract: A catalytic converter for cleaning exhaust gas from an internal combustion engine, in particular a diesel engine or a lean-burn engine, includes at least one honeycomb body coated with catalytically active material and having passages through which the exhaust gas can flow, walls separating the passages from each other, and first and second zones disposed in succession in a flow direction. The first zone has a lower thermal capacity per unit of volume of the honeycomb body than the second zone and the second zone has a thermal capacity of at least 800 joules per liter and Kelvin [J/lK], preferably at least 900. Sheet metal layers in the first zone preferably have an average uncoated thickness of less than 0.06 mm, preferably less than 0.04 mm. Sheet metal layers in the second zone preferably have an average uncoated thickness of more than 0.06 mm, preferably more than 0.08 mm and in particular 0.11 mm.

Abstract: An electric ozone toothbrush mainly has a guide tube installed in an interior portion of a handle and a brush head of a regular electric toothbrush connecting with a bristle end of the brush head; the other end of the guide tube joins with a coil tube of an ozone generator; an air pump disposed inside the ozone generator guides the ozone into the bristle end of the brush head such that the released ozone sterilizes, deodorizes, whitens the teeth, disinfects and detoxifies during the brushing application of the electric toothbrush.

Abstract: A system for the continuous use and recapture of a catalyst in liquid, comprising: a generally vertical reactor having a reaction zone with generally downwardly flowing liquid, and a catalyst recovery chamber adjacent the reaction zone containing a catalyst consisting of buoyant particles. The liquid in the reaction zone flows downward at a rate which exceeds the speed of upward buoyant migration of catalyst particles in the liquid, whereby catalyst particles introduced into the liquid in the reaction zone are drawn downward with the liquid. A slow flow velocity flotation chamber disposed below the reaction zone is configured to recapture the catalyst particles and allow them to float back into the catalyst recovery chamber for recycling into the reaction zone, rather than being swept downstream. A novel 3-dimensionally adjustable solar reflector directs light into the reaction zone to induce desired photocatalytic reactions within the liquid in the reaction zone.

Abstract: The invention relates to a reactor vessel and method for the gasification of carbon-containing fuel, residual and waste materials using an oxygen-containing oxidizing agent and in a reaction chamber which is designed as an entrained-bed reactor, at pressures between ambient pressure and 80 bar, preferably between ambient pressure and 30 bar, the contour of the reaction chamber being delimited by a cooling system, and the pressure in the cooling system always being held at a higher level than the pressure in the reaction chamber, and the cooling system withstanding the maximum possible pressure difference with respect to the reaction chamber, which has been depressurized to atmospheric pressure, which reactor vessel is distinguished by the fact that cooling channels are formed by webs which are in contact both with a refractory protective layer and with the pressure shell.

Abstract: A sterilization tray system which comprises an outer box-like case having holes in the case bottom wall through which steam or other sterilant may circulate through the case. Pairs of brackets are affixed vertically to opposite the case side and/or end walls. A plurality of spaced holes is provided in each bracket. The holes serve as anchoring points for shelf brackets or fixtures for supporting trays at selected positions in the case.

Abstract: A chemical process for the purification of CaSO4 utilizes the ability of an aqueous solution of a chelating agent to selectively dissolve CaSO4 in that the initial extraction can be carried out at certain pH and CaSO4 can be recovered by titration to a different pH (usually a a lower pH) following a mechanical treatment, such as centrifugation or filtration, to separate the aqueous chelate solution from insoluble material. Also claimed are an apparatus and the use of chelating agents therefor.

Abstract: Rare earth metal containing compounds of the general formula Sr2RESbO6, wherein RE is a rare earth metal, have been prepared with high critical temperature thin film superconductor strucutures, and can be used in other ferroelectrics, pyroelectrics, piezoelectrics, and hybrid device structures.

Abstract: A preparation method of silica, especially superfine silica, with water glass and carbon dioxide as major raw materials in a carbonization reaction conducted under a high gravity field, typically in a Higee reactor.

Abstract: A catalyst for oxidation reactions, particularly the oxidation of ammonia comprises oxides of (a) at least one element A selected from rare earths and yttrium, and (b) cobalt and element A being in such proportions that the element A to cobalt atomic ratio is in the range 0.8 to 1.2, at least some of said cobalt and element A oxides being present as a mixed oxide phase with less than 25% of the cobalt (by atoms) being present as free cobalt oxides, is disclosed. The catalyst may be supported on a secondary support in the form of an alkali-free alumina or lanthana wash coat on a primary support in the form of a mesh, gauze, pad, or monolith formed from a high temperature iron/aluminum alloy or a mesh, gauze, pad, monolith, or foam of a ceramic material.

Abstract: This invention is directed to making chemical derivatives of carbon nanotubes and to uses for the derivatized nanotubes, including making arrays as a basis for synthesis of carbon fibers. In one embodiment, this invention also provides a method for preparing single wall carbon nanotubes having substituents attached to the side wall of the nanotube by reacting single wall carbon nanotubes with fluorine gas and recovering fluorine derivatized carbon nanotubes, then reacting fluorine derivatized carbon nanotubes with a nucleophile. Some of the fluorine substituents are replaced by nucleophilic substitution. If desired, the remaining fluorine can be completely or partially eliminated to produce single wall carbon nanotubes having substituents attached to the side wall of the nanotube. The substituents will, of course, be dependent on the nucleophile, and preferred nucleophiles include alkyl lithium species such as methyl lithium.

Abstract: A process for producing hollow, single-walled carbon nanotubes by catalytic decomposition of one or more gaseous carbon compounds by first forming a gas phase mixture carbon feed stock gas comprising one or more gaseous carbon compounds, each having one to six carbon atoms and only H, O, N, S or Cl as hetero atoms, optionally admixed with hydrogen, and a gas phase metal containing compound which is unstable under reaction conditions for said decomposition, and which forms a metal containing catalyst which acts as a decomposition catalyst under reaction conditions; and then conducting said decomposition reaction under decomposition reaction conditions, thereby producing said nanotubes.

Abstract: A method for preparing barium fluorohalide-based crystal, which includes at least a step in which a halide aqueous solution (B) and aqueous solutions of a fluoride and a barium salt are mixed into a halide aqueous solution (A). The halide aqueous solution (B) contains the same halogen as that contained in the halide aqueous solution (A). In this method, halide ions are used efficiently rather than remaining to form a waste residue.

Abstract: Ultrafine powders of Li4Ti5O12 with particles in the size range of 25-500 nm. The average size of particles is about 500 nm of less, preferably about 300 nm or less. The particles are composed of nanocrystallites, which have an average size about 30 nm. This invention also includes the method of producing these ultrafine Li4Ti5O12 particles. The process utilizes (i) nanoparticles of TiO2, (ii) a lithium salt, and (iii) an organic solvent with a boiling point in the range of 70-230° C. The process is carried out at pressures in the range of 0.5 to 10 atmospheres. The inorganic salt of Li is mixed with TiO2 nanoparticles (˜20-25 nm) in the organic solvent. The solution is heated to a temperature and at a pressure to facilitate the diffusion of Li ions in to nanoparticles. After completion of the reaction, the powder is heat treated in O2 or an inert gas to form the desired phase.

Abstract: A process for producing a titanium oxide is provided which comprises (i) a step of calcining a titanium compound in the presence of ammonia gas or (ii) steps of treating a titanium compound with heat in the presence of ammonia gas and calcining the heat-treated titanium compound. The titanium oxide obtained in the present invention exhibits a sufficiently high photocatalytic activity by irradiation of visible light.

Abstract: Aluminium hydroxide of high whiteness is produced by (i) heating aluminium hydroxide obtained from the Bayer process to a temperature of 300 to 700° C. (ii) dissolving the soluble fraction of the thus obtained activated product at 85 to 275° C. in aqueous sodium hydroxide to form a sodium aluminate liquor containing an undissolved residue of very fine boehmite, (iii) filtering said sodium aluminate liquor to obtain a clear solution of sodium aluminate supersaturated with respect to dissolved alumina, (iv) cooling said clear solution to 50 to 80° C. and seeding with crystallized aluminium hydroxide to induce further crystallization, and (v) separating, washing and drying the produced aluminium hydroxide crystals.

Abstract: The present invention relates to the preparation of nanocrystalline zeolite beta by a modified aerogel protocol comprising four steps, namely, hydrolysis, nucleation, crystallization and supercritcal drying.

Abstract: Specific binding members, based on the third CDR of the antibody NHS76 (SEQ ID NO: 2) are provided, together with their use in methods of treatment and diagnosis.

Abstract: Metallotetrapyrrolic compounds having photherapeutic properties useful in photodetection and phototherapy of target issues, particularly porphyrins and azaporphyrins that including gallium in the central pyrrolic core. Also disclosed are methods of using metallotetrapyrrolic compounds for the treatment or detection of cardiovascular disease.

Abstract: The invention concerns a racemic compound of the pair of enantiomers of formula (III) wherein R represents an alkyl group or a phenyl group optionally substituted.

Abstract: The subject-matter of the present invention is a transfer-free composition comprising (a) at least one of a di-block, tri-block, multi-block and/or radial block copolymer and optionally (b) a film former or a mixture of film formers. The composition may comprise any one of a di-block, tri-block, multi-block or radial block copolymer or any mixture or blend of co-polymers. Cosmetic and pharmaceutical compositions of the invention result in a film with very good retention, good transfer resistant properties, and which does not migrate over time. The compositions have cosmetic properties which are improved in relation to those of the “transfer free” products of the prior art.

Abstract: A composition comprising 1-25 wt. % of a silicone gum, 1-40 wt. % of a silicone fluid having a viscosity of 10 to 60,000 mm2/sec, 1-35 wt. % of a silicone wax and 20-90 wt. % of a volatile silicone fluid having a viscosity up to and including 5 mm2/s at 25° C. can be used for the treatment of scars resulting from injury or surgery.

Abstract: A sport fishing system having: a rod and reel, including fishing line; at least one fishing lure or natural bait; and a controlled released fish attractant for applying to the fishing lure or natural bait. The system may further include an applicator for applying the controlled released fish attractant to the fishing lure or natural bait. In the preferred embodiment, the controlled release fish attractant includes: an attractant and a substantially hydrophobic, film forming release agent.

Abstract: Methods for treating endocrine disorders and for inhibiting gametogenesis by intracranial administration to a human patient of a therapeutically effective amount of a neurotoxin, such as a botulinum toxin type A.

Abstract: The invention provides a composition which is effective in the prevention or delay of the onset of side effects associated with alcohol consumption or the reduction or alleviation of those effects. The composition of the invention includes activated charcoal and limestone, optionally activated limestone. Optionally, the composition of the invention also includes vitamin B1 and/or other agents such as fatigue relieving agents. Preferably, the composition of the invention is provided in the form of tablets or powder encapsulated in a gelatin capsule. The composition of the invention is provided in pre-dosed quantities varying from between about 100 and 500 milligrams per dose. The invention also provides a method of reducing or alleviating the deleterious effects associated with alcohol consumption.

Abstract: A purified human papillomavirus gene selected from the group consisting of E1, E6-E7, L1, and L2, wherein said human papillomavirus is selected from the group consisting of HPV-2d, HPV-10b, HPV-14a, HPV-14b, HPV-15, HPV-17a, HPV-17b, HPV-19, HPV-20, HPV-21, HPV-22, HPV-23, HPV-24, HPV-28, HPV-29, HPV-31, HPV-32, HPV-IP2 and HPV-IP4. Polypeptides encoded by these genes. The polypeptides can be used in immunogenic compositions.

Abstract: The invention relates to a humanized anti-B7-2 antibody that comprises a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The invention also pertains to methods of treatment for various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases by administering humanized anti-B7-2 and/or anti-B7-1 antibodies.

Abstract: A method of inhibiting, moderating or diagnosing Pseudomonas aeruginosa infection is disclosed. In one embodiment, this method comprises inoculating a patient with an effective amount of PcrV antigen.

Abstract: Vaccine compositions and immunogenic compositions are described which are glucosyltransferase subunit vaccines for dental caries and which contain at least one peptide which corresponds to a sequence of glucosyltransferase containing aspartate 413, an equivalent of aspartate 413, aspartate 451, an equivalent of aspartate 451, aspartate 562, and equivalent of aspartate 562, aspartate 567, an equivalent of aspartate 567, histidine 561, an equivalent of histidine 561, tryptophan 491, an equivalent of tryptophan 491, glutamate 489, an equivalent of glutamate 489, arginine 449, an equivalent of arginine 449, or combinations thereof. These subunit vaccines elicit antibodies which protect an immunized mammal from dental caries. Methods of provoking an immune response to intact glucosyltransferase are also described.

Abstract: This invention relates to hepatitis B virus (“HBV”) core antigen particles that are characterized by multiple immunogen specificities. More particularly, the invention relates to HBV core antigen particles comprising immunogens, epitopes, or other related structures, crosslinked thereto by ligands which are HBV capsid-binding peptides that selectively bind to HBV core protein. Such particles may be used as delivery systems for a diverse range of immunogenic epitopes, including the HBV capsid-binding peptides, which advantageously also inhibit and interfere with HBV viral assembly by blocking the interaction between HBV core protein and HBV surface proteins. Mixtures of different immunogens and/or capsid-binding peptide ligands may be crosslinked to the same HBV core particle. Such resulting multicomponent or multivalent HBV core particles may be advantageously used in therapeutic and prophylactic vaccines and compositions, as well as in diagnostic compositions and methods using them.

Abstract: Materials and methods for improving kidney function or enhancing proliferation or survival of kidney tubule epithelial cells or epithelial cell precursors in a mammal are disclosed. The methods comprise administering to the mammal a composition comprising a therapeutically effective amount of a zvegf4 protein or a zvegf4 protein-encoding polynucleotide in combination with a pharmaceutically acceptable delivery vehicle. Zvegf4 proteins include, for example, disulfide-bonded dimers of two polypeptide chains, each comprising residues 258-370 of SEQ ID NO:2.

Abstract: The peptide in this invention is a peptide having affinity to gp120 represented by H-A1-A2-A3-A4-A5-R (SEQ ID No. 1)  Formula (1) (in the formula, H means hydrogen, A1 is aspartic acid, lysine, valine, glutamic acid, glycine, asparagine, or tyrosine residue, A2 is valine, aspartic acid, tryptophan, lysine, phenylalanine, isoleucine, leucine, or tyrosine residue, A3 is lysine, valine, aspartic acid, arginine, alanine, or tryptophan residue, A4 is alanine, tryptophan, or glycine residue, A5 is glycine, alanine, valine, leucine, isoleucine, serine, threonine, methionine, asparagine, glutamine, histidine, lysine, arginine, phenylalanine, tryptophan, proline, or tyrosine residue, R is OH derived from carboxyl group or NH2 derived from acid amide group).

Abstract: A method of obtaining a pharmacologically active extract of the cell walls of Gram-positive bacteria is disclosed. The method involves the treatment of the bacteria with acid such that the immune-stimulating properties are enhanced. The extracts have immune stimulating and anti-tumor activities with no toxicity at effective doses. The final products are stable, water-soluble powders.

Abstract: Carotenoid aggregates are useful as colorants for foods and for cosmetic and pharmaceutical preparations.

Abstract: A liquid composition comprising an alcohol or mixture thereof in sufficient quantity to grow hair in an area of canine or feline skin wherein alopecia has occurred.

Abstract: Described are dermatological compositions for treating, protecting and re-epitheliazing cutaneous wounds and damaged skin, such compositions including about 21 to about 40% urea and trace amounts of zinc, copper and manganese in the form of their respective pharmaceutically acceptable salts.

Abstract: Provided is a composition for percutaneous administration containing a mixture of polymers forming a surface-segregated film, and (B) an active ingredient. The composition provides excellent percutaneous absorption efficacy of the active ingredient, particularly, a water-soluble active ingredient, has excellent feeling and is convenient to use.

Abstract: A nutritional supplement for providing, and for promoting the health of salivary glands and/or supporting normal or healthy swallowing includes ingredients obtainable from turmeric, ginger, and horseradish. The nutritional supplement may also be used to treat symptoms such as symptoms of a common cold, sore throat, congestion, mucositis, laryngitis, mucous membrane inflammation and sialorrhea, as well as inflammation and viral infectin, or to inhibit or exterminate a virus. This nutritional supplement can be orally administered a person. The nutritional supplement may further include optional ingredients such as ingredients obtainable from slippery elm bark powder and green tea, as well as other optional ingredients. This nutritional supplement may further include a pharmaceutically acceptable carrier for oral administration.

Abstract: Compositions comprising both a sedative and a non-sedative antihistamine are disclosed as well as methods of inhibiting the release of histamines by administration of the compositions to a mammalian subject.

Abstract: A film coating composition suitable for use in coating pharmaceutical formulations to provide modified release comprising a dispersion which includes: a) an acrylic polymer, b) a vinyl acetate polymer, and c) a water-containing liquid. The film coat is useful for the achievement of modified release from pharmaceutical formulations such as tablets, pellets, etc.

Abstract: The present invention provides a method and compositions for processing poultry feathers. In one embodiment, the method for processing poultry feathers comprises contacting a plurality of poultry feathers having an average particle size with a detergent capable of imparting a static charge to the plurality of poultry feathers; reducing the average particle size of the plurality of poultry feathers; increasing entanglement of the plurality of poultry feathers; adding an anionic polymeric adduct to the plurality of poultry feathers; adding a cationic species to the plurality of poultry feathers; and dewatering the plurality of poultry feathers. In another embodiment, a composition for processing poultry feathers, comprises a detergent capable removing at least a portion of fats and oils from a poultry feather and imparting a static charge to the poultry feather; an antimicrobial compound; an anionic polymeric adduct; and a cationic species.

Abstract: A wood preservative that comprises as an active ingredient a Piper methysticum, plant or a processed product thereof or a compound represented by Formula (I): wherein R1, R2, R3, R4 and R16 are same or different and each denotes a hydrogen atom, hydroxy or a C1-4 alkoxy, or R1 and R2 are taken together to form a group represented by —O—(CH2)n—O— wherein n is an integer of 1 to 3, R5 is a C1-4 alkoxy and X is —CH═CH—, —CH2—CH2— or epoxyethylene, and the bond: denotes a single bond or a double bond can prevent the attacking wood by an insect harmful to the wood and also prevents the appearance and the growth of a wood-rotting fungus or a wood- staining fungus while being highly safe to humans and animals without exerting no adverse effect on the environment.

Abstract: The present invention relates to Aralia extracts and a therapeutic agent comprising Aralia extracts as an active ingredient. The composition and therapeutic agent according to the present invention are effective in preventing cataract, delaying the development of cataract, and treating cataract. According to the present invention, extracts of Aralia are obtained by extraction with alcohol. Addition of myo-inositol or taurine to the extracts will result in a synergistic effect in the treatment of cataract. In addition, oral administration of beverages, galenicals, and nutraceuticals, which comprise Aralia extracts as an active ingredient, will be effective in prevention, delay and treatment of cataract caused by complications of diabetes. Aralia extracts will have the same effect in the case where they are used as an ophthalmic agent. They can also be used as an eye drop or an eye ointment.

Abstract: A method is provided for effecting smoke detoxification in a human by using a composition that is made of effective amounts of supercritical extract and hydroalcoholic extract of turmeric.

Abstract: Lactobacillus sanfranciscencis strains according to the present invention having a property for producing a non-organic acid antibacterial agent which exhibits at least mold-proofing activity. A fermented seasoning liquid of Lactobacillus according to the present invention may contain a Lactobacillus strain having a property for producing an antibacterial agent that inhibits the growth of mold. A method for producing bread according to the present invention may involve the use of a fermented seasoning liquid of a Lactobacillus strain having a property for producing an antibacterial agent which inhibits the growth of mold to make bread.

Abstract: The present invention provides a composition comprising an untreated or treated culture of a mixed microorganism and a functional food comprising said composition. A composition comprising an untreated or treated culture of a mixed microorganism comprising at least three lactic acid bacteria selected from the group consisting of Lactobacillus delbrueckii, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus rhamnosus, Lactococcus lactis and Streptococcus thermophilus, mixed with Saccharomyces cerevisiae, and a functional food comprising said composition.

Abstract: The present invention relates to tasty, ready-to-eat, nutritional foods that offer an alternative to appealing but unhealthy foods. More particularly, tasty, ready-to-eat, nutritional foods that provide a balanced mix of amino acids, fat, and carbohydrates are disclosed. Processes for making, and methods of using said tasty, ready-to-eat, nutritional foods are also disclosed. The nutritious foods of the present invention are formulated and processed such that they resolve the dilemma that consumers have always been faced with—healthy eating or enjoying what they eat.

Abstract: The present invention is a high-protein foodstuff that contains at least two layers wherein at least one of the layers contains at least 25% of protein and wherein the high-protein foodstuff may further contains of a high protein coating. The present invention is also directed to methods for making the high protein foodstuff, optionally with a high protein coating.